chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came back to health unit approximately 3 hrs after vaccine administration with complaints of itching. Treated per school nurse. Pt. reported had similar symptoms with previous vaccination, but did not relay this information to us prior to administration.
Client received Pfizer COVID-19 vaccine. A couple minutes after injection, client reported feeling warm and removed his sweatshirt. A few minutes after that, about 5 minutes after injection, he appeared pale and then lost consciousness. He remained upright in the chair with support and did not sustain any injuries. He was unconscious for about 1 minute, with slight jerking movements prior to regaining consciousness. He was moved to an exam table to lay down, ice packs applied to neck and cheek, and drank a few sips of Sprite. He experienced trembling in his left leg and hands and arms, which subsided after 5-10 minutes. He reported some pain on the inside of his left cheek, possibly from biting his cheek during the jerking movements. No blood or significant injury was observed in that area. After 10-15 minutes, he was stable enough to sit, and then stand, and them ambulate. Client reported eating a small breakfast that morning, and vaccine was given during his normal lunch time at the facility. He had also just come from a stressful meeting.
wooziness; vomiting; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (wooziness) and VOMITING (vomiting) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 044B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced DIZZINESS (wooziness) and VOMITING (vomiting). At the time of the report, DIZZINESS (wooziness) and VOMITING (vomiting) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Information has been received from a nurse practitioner concerning a female who on 02-JUL-2008 was vaccinated with oral ROTATEQ vaccine live (human-bovine). Concomitant therapy included "other vaccines" (therapy unspecified). A phone call was received from the parent of the baby patient because the baby's tongue turned black after receiving ROTATEQ vaccine live (human-bovine) vaccine. Lot # was not available. Per nurse practitioner, the patient is now recovering. Unspecified medical attention was sought. Additional information has been requested.
Information has been received from a health professional concerning a 54 year old female with high cholesterol and no allergies or drug reactions who on 09-OCT-2006 was vaccinated intramuscularly into the right arm with a 0.5 ml dose of Pneumovax 23 (lot #651400/0618F). Concomitant therapy included CENTRUM and AMBIEN CR. That same day the patient experienced pain that went to the shoulder and down the right arm like a dull ache and tenderness at the injection site. On 10-OCT-2006 the patient took two ADVIL, three times for the pain. It was noted that if the patient did not take the ADVIL, the pain would be worse. Unspecified medical attention was sought. No lab studies were performed. At the time of report the patient had not recovered. No product quality complaint was involved. It was also reported that the patient's "last vaccination" was 13 years ago. Additional information has been requested.
sore arm in the injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (sore arm in the injection site arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced INJECTION SITE PAIN (sore arm in the injection site arm). At the time of the report, INJECTION SITE PAIN (sore arm in the injection site arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-086345 (Patient Link).
Pt recvd DTP/OPV/HIB/ & again devel eye infect; mom thinks pt devel eye infect from HIB vax; pt has plugged tearduct also;
Patient came into the pharmacy and said that he felt fine yesterday when he received the shot. Patient came back to the pharmacy and explained that he hasn't been feeling good today. He said that he is feeling nauseous and light headed. Explained to him that some people feel under the weather when getting the shot, but I haven't heard of nauseous or light headed (the day after). Instructed him to follow up with  his physician.
Patient was administered 0.2ml of an undiluted  Pfizer 5-11 y/o pediatric vaccine. Patient has had no adverse effects.
Pt recvd MMR vax 16AUG91 & in SEP91 exp polyarthritis; c/o stiffness & dec in energy; PE showed synovitis; Lab eval show inc ESR & antinuclear antibody & rheumatoid factor pos; x-ray showed soft tissue swelling of the rt knee; MD felt JRA;
High fever, chills, aches, weakness, fatigue, headache, arm soreness.
Patient broke out in shingles 6 days after vaccination was administered. Pat She is being treated by her primary care physician accordingly.
Feb 20th Stomach Pain + bladde full thought UTI Feb 27th Burning when urinate/urGENT CARE Gave Bactrim  Feb 29th SKin Leisons at Base of Spine stopped Bactrim March 4th Thyroid Dr sAID either BACTRIM FLASH or Shingles March 5th Womens Health DR TesTED IGG + IMG SAiD shingles mayBE March 31st Lymph pAin severe/start Tylenol every 6 hours. April 7th see GP she examines pAin Right side/Right Neck  Right Arm Down to wrist. Does Blood No Findings. Results Not sure if shingles or Covid ShoT My Immunities Feb 6th COVID shot Right ARM Feb 20th UTI symptoms: I tRy to treat NaTurally Feb 27th Urgent CARE for Burning Below DR GIVES - BACTRIM Feb 29th stopped BACTRIM UTI culture Negative March 1st severe Leisons at BASE of Spine March 4th SAW ThyroiD Dr. He says either BACTRIM  FLash oR shingles from Covid Shot my  Immuno system could not handle it "Quote: Thyroid Dr." "I told you not To GET it."  March 5th Go to Women Health Dr. Skin at Base of spine irritated painful to touch She gives  me clobetasol Propionate Ont. 0.05% 3-4 x/day Does IGG TEST NumBERS High Repeat 4-6 weeks.  7 DAys Later HEALED.  MaRch 31st  Wake up with severe pain. though Lymph Nodes Right side under arm/Right Neck/Right Arm Dull pain from shoulder to wrist comes + goes.  STArT TylenoL every 6 hours / Ice for 7 DAys Call GP. Doctor on 6th DAy still stabbing pain ApriL 7th Right Lymph Arm to my RIGHT WING AT Dr's office DR. EXAmines inconclusive thinks might be Shingles BuT NO Leisons. Does Blood Test  EVERything fine  D-Dimer Number Little bit up does  NOT THINK Blood Clot.  ApriL 9th - STiLL PAiN Right BACK SHArp. No shingles/sKin irritant showing. Right wing area.  WRiting to Document Because I found this ARTicle  Just to Let you know I was healthy Before this  shot and Lost 40 lbs. Last year and bicycle rode 6.5 miles 3-4 x/week. I can not Do that Now. Fatigue + pAin.  4/15/21 Day 68 since 2nd shot - I am 85% with continued pain in Lymph gland.  STill NoT 100% PAIN FREE.
stomach cramps and nausea for some hours every day since vaccination. edema in left leg and foot 2 weeks after second dose
6 hours after vaccine- chills, massive headache, tired 24 hours after- fever, headache  3 days after (today)- enlarged lymph node on left side neck, hot spells, left ear feels clogged
At 5 AM a few jerking episodes day after vaccine, macular/papular eruptions lower extremities in first 24 hours then progressed to upper extremities, fever to 99 - 100 degrees  for 3 days after shots. Would not crawl or ambulate for 3 days.
shoulder area near the injection site became red; shoulder area near the injection site became swollen; shoulder area near the injection site became tight; shoulder area near the injection site became itchy; shoulder area near the injection site had a blotchy redness; Right arm felt sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy) and RASH MACULAR (shoulder area near the injection site had a blotchy redness) in a 54-year-old male patient who received mRNA-1273 (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore). On 09-Apr-2021, VACCINATION SITE ERYTHEMA (shoulder area near the injection site became red), VACCINATION SITE SWELLING (shoulder area near the injection site became swollen), VACCINATION SITE INDURATION (shoulder area near the injection site became tight), INJECTION SITE PRURITUS (shoulder area near the injection site became itchy), RASH MACULAR (shoulder area near the injection site had a blotchy redness) and VACCINATION SITE PAIN (Right arm felt sore) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.
Already had tinnitus, but now aggravated. Temporary lose hearing on one side, comes back in 30 seconds with loud tinnitus, which decreases over time.
Metallic taste in mouth, even when not eating.  Metallic taste continued for approximately 24 hours
Patient received a PEDVAXHIB in error. Pneumonia vaccine ordered. When patient was notified she said she experienced dizziness and a sense of euphoria as she was leaving the clinic. Patient returned to clinic with same symptoms shortly after getting vaccine.
Received Tdap (Sanofi Lot # U3979DA exp 12/1/13) at 9:30 AM 9-10-11 at county sponsored clinic - at about 6:30 PM began to experience cough (which became productive) with body aches and pains and low grade fever - no soreness in arm or at site of injection.
passed away 19Jun2021; This is a spontaneous report from a contactable consumer (patient's mother). A 25-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 23May2021 (Lot Number: EW0172) (at age of 25-year-old) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included diagnosed with an enlarged vessel sized heart.  The patient's concomitant medications were not reported. The patient experienced passed away on 19Jun2021.An autopsy was performed and results were not provided. Two days after the first vaccine was when the information came out about males 20-30 getting inflammation of the heart. The patient's mother told him not to take the second shot. Then, this happened. She doesn't have the results of the autopsy yet. She believed the Pfizer vaccine escalated his death. He did get diagnosed with an enlarged vessel sized heart. He got it because he thought he was doing the right thing.  There was no history of all previous immunization with the Pfizer vaccine considered as suspect.  No additional Vaccines Administered on Same Date of the Pfizer Suspect. No Prior Vaccinations (within 4 weeks).  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: passed away 19Jun2021
Chills, fever, upset stomach, headache. Chills and fever were overnight for a few hours. Upset stomach and headache lasted about 12 hours
Patient received vaccine after expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 3J972, expiry date 20-AUG-2024) for prophylaxis.   On 26-SEP-2023, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion).  The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 28-Sept-2023 No symptoms were reported. The reporter consented to follow-up via email. This is 1 of 3 linked cases reported by the same reporter. The patient received a dose of Shingrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023133819:same reporter different patient. US-GSK-US2023133821:samereporter, different pateint,different drug.
61-year-old patient was online to sign up. After being vaccinated, the paramedic felt dizzy and was taken to the Tx area. The patient presented nausea, pale skin, and dizziness. Patient was evaluated and placed in anti-shock position. Patient was observed for half an hour. Patient reports feeling fine, she no longer feels nauseous, re-evaluated patient reports that she does not want to go to the hospital, she wants to leave, she is hungry.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), in Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 63 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Sleep apnea" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (25Jun2022) Positive, notes: New positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Daughter called on 9/13/2021. Reports patient began having palpitations the day after the vaccine. She thought the palpitations was due to anxiety and did not wish to go to the ED. She had a friend who was passing away and she was slightly upset. She continued to have some symptoms. On 3/28/2021, she passed away.
Dizziness; Vertigo; Dull Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo) and HEADACHE (Dull Headaches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HEADACHE (Dull Headaches). On 06-Feb-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Vertigo). The patient was treated with MECLIZINE [MECLOZINE] ongoing since an unknown date for Vertigo, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo) and HEADACHE (Dull Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
He experienced a burst blood vessel in his eye 3 day later; This is a spontaneous report from a contactable consumer. This male consumer (patient) reported for himself.  A male patient of an unspecified age received bnt162b2 (BNT162B2 solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation  .  The patient medical history and concomitant medications was not reported. It was reported that on an unspecified date the patient had a burst blood vessel in his eye 3 day later after administration of vaccine. Outcome of the event was unknown.  Information about lot/batch number was not available. Further information expected.
redness over inj site onset 48hr p/vax;no tx;improved at 72hr;
Swollen armpit lymph node on same side as shot a few days after the shot and then about a week after the shot a itchy, red rash that is warm to the touch on the same arm.
Tennis ball size swelling of lymph notes in Right armpit.  Discovered 36 hours after shot.  Only other symptom is pain in right arm that required OTC ibuprofen.
Recevied vaccine on 5/14 around 6 pm. Started noticing chest pain, chills and fatigue on 5/15 around 6 pm. Evaluated by ED on 5/17 subsuquently admitted to PICU with intermittent chest pain and elevated troponin in the setting of recent Covid vaccination as well as a history of WPW status post ablation with recent onset of intermittent tachycardia. EKG demonstrates nonspecific ST segment changes and has elevated troponin which likey points to myocarditis as a diagnosis. Continues with elevated troponin level, no medication intervention at this time, no longer having chest pain
Morning after flu vaccine (R) upper arm sore and noted significant soreness in (R) upper arm when removing clothing over my head. These symptoms gradually worsened over 3 wks. At 3 weeks visit to my F.P. MD et he diagnosed supraspinatus tendonitis (R) shoulder. Followed with home P.T. at 5 weeks symptoms persist, but at times are improved. No previous injury or pain history to (R) shoulder.
Parents stated "crying since receiving shots" unrelieved with tylenol or motrin, fever 102 to 105 (stated), cough and runny nose.   Seen in office for recheck 0800 day after immunization, child unconsolable,  admitted to hospital for observation. The medical record states irritability.
Shortness of breath, feeling like someone sitting on chest, heart racing, extreme chills, diarrhea, and fever of 101.4
Headache, NauseaVomiting, HYPERtension, lupus flare up with hypertensive emergency  Narrative:
Patient awoke 04/09/2021 with visual disturbance and limited field of vision.  Went to eye center and was evaluated.  MD at eye center sent him to ER and told patient that it appeared he was having a stroke.  Admitted to medical center 04/09/2021.  Patient reports he was diagnosed with a stroke affecting the occipital region that affects his vision.  Patient was discharged from the  hospital 04/11/2021.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 75-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Sep2023 as dose 1, single (Lot number: HM7595) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: product=COVID 19 Treatment, brand=Pfizer; Treatment start date=15Oct2023; Treatment stop date=19Oct2023; indication=Treatment of COVID-19.
(L) arm 4 x 4 cm redness, hard & tender. Bruise above red area - vaccine site. Went to ER - received antibiotic, BENADRYL, steroid & pain pill site observed by health dept 1/28/11 when reading PPD.
24 hours after injection: 102 temp, extreme exhaustion, loss of appetite, pain in stomach.  Temp reduced not 99.3 two hours after 102 reading. 38 hours after injection, mildly sore stomach.  No further exhaustion.
Pfizer Booster Dose # 2 was administered before patient was 50 years of age.
DTaP/IPV given to 16 year old patient for tetanus series to get caught up on vaccines for school. These vaccines are still valid per CDC (will not need re-vaccination to get caught up and can continue on current catch up schedule). Tolerated the vaccine well. No signs/symptoms reported to us following this vaccination.
shingles presentation that started on 5/27/2021, placed on antivirals on 6/1/2021
Pain in left thigh, treated with pain killers and stretching, also stopping astorvastatin to see if it was a side effect.  Pain lessened but not removed by stopping drug. Waiting to see how cholesterol does without drug.
Hard lump at the injection site; This spontaneous report has been received from a pharmacist via company representative regarding a 13-year-old male patient.  The patient's concurrent conditions, historical conditions, and concomitant therapies were not reported.  On an unspecified date (reported as several months ago), the patient received the first dose of HPV RL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 mL 2 or 3 dose series (patient route of administration, anatomical location, lot number and expiration date was not provided) as HPV prevention.   Later on an unspecified date after the patient's vaccination, he had a hard lump at the injection site (vaccination site mass). Later, the vaccination site had remained free for symptoms other than the hard bump experienced, and the patient had not had any other report of symptoms since the vaccine was administered; consequently on an unspecified date he recovered from the event vaccination site mass.  The causal relationship between the event and HPV RL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was unknown.